Innoprot is a biotechnology company that provides products and technologies for cell-based assays in drug discovery and development, including primary cells, immortalized cell lines, and recombinant cell lines. It uses proprietary technology for high content screening. The company also provides contract research screening services focused on GPCRs, fibrosis, and neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease, or amyotrophic lateral sclerosis.